[Antioxidant probucol prevents development of alloxan diabetes and decrease of antioxidant enzyme activity in rat tissues].
Korchin
V I
VI
Lankin
V Z
VZ
Iarkova
R D
RD
Konovalova
G G
GG
Smirnov
L D
LD
Kukharchuk
V V
VV
D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000201:enzymology / Q000378:metabolism* / Q000517:prevention & control; D005979:Glutathione Peroxidase / Q000032:analysis*; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000201:enzymology*; D008099:Liver / Q000201:enzymology*; D011341:Probucol / Q000494:pharmacology*; D051381:Rats; D013482:Superoxide Dismutase / Q000032:analysis*
D007328:Insulin; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D011341:Probucol
Antioksidant probukol predotvrashchaet razvitie alloksanovogo diabeta i snizhenie aktivnosti antioksidantnykh fermentov v tkaniakh krys.